Skip to main content
. Author manuscript; available in PMC: 2015 Aug 15.
Published in final edited form as: Cancer. 2014 May 6;120(16):2403–2411. doi: 10.1002/cncr.28756

Figure 3. Percentage of patients who discontinued aromatase inhibitor (AI) therapy according to the number of symptoms present prior to AI initiation.

Figure 3

The number of patients in each group is given below the x axis. OR: odds ratio.